WuXi AppTec and its affiliates faced volatile trading after the introduction of a revised version of the Biosecure Act by U.S. lawmakers that gives U.S. companies time until 2032, after which business tie-ups with the named Chinese biotech firms would be restricted. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
